COMPULA
Nicotinamide Mononucleotide (NMN)
89/100
SUPPIE SCORE
72/100
EFFICACY
High
SAFETY
100/100
CLEANLINESS
What Does Nicotinamide Mononucleotide (NMN) Do?
500 mg NMN daily matches the lower end of studied doses that reliably raise blood NAD+; human trials show modest physical performance gains at 300–1200 mg with peak effects near 600 mg and no serious safety signals up to 24 weeks.
What dose of NMN shows the strongest NAD+ increase in trials?
How does 500 mg daily NMN compare to higher doses for physical performance?
Are there any known interactions between NMN and common medications?
Chat with Suppie
What Are the Benefits of Nicotinamide Mononucleotide (NMN)?
Based on proven scientific research
NAD+ increaseStrong
Physical enduranceModerate
Walking capacityModerate
General health perceptionMild
Good For:
What Are the Side Effects of COMPULA Nicotinamide Mononucleotide (NMN)?
Always consult your health practitioner if in doubt.
RiskLow Risk
Overview
•Doses up to 1200 mg daily showed no increase in adverse events across multiple RCTs
•No significant changes in liver enzymes ALT or AST reported in meta-analyses
•Well tolerated for 4–12 weeks in healthy middle-aged and older adults
•Evidence limited beyond 24 weeks; longer-term safety data sparse
Potential Side Effects
Negative Interactions
Inactive Ingredients
Safe Formulation!
Great news, this product doesn't contain harmful ingredients!
What Are the Ingredients in COMPULA Nicotinamide Mononucleotide (NMN)?
Serving Stze: 2 Capsules Bervings Per Container: 30 count Per Serving 9 DV Nicotinamide Mononucleotide (NMN)
500mg
Dosage & Bioavailability
How the active doses and forms in Nicotinamide Mononucleotide (NMN) compare to the research.
•Nicotinamide Mononucleotide (NMN) — 500mg; studied range 250–1200 mg/day for 4–12 weeks with NAD+ increases observed.
•Nicotinamide Mononucleotide (NMN) — 500mg; the label does not disclose an extract standardisation percentage or marker amount.
Frequently Asked Questions
Common questions about COMPULA Nicotinamide Mononucleotide (NMN)